Aceglutamid
Nazivi | |
---|---|
IUPAC naziv N2-Acetilglutamin | |
Drugi nazivi α-N-Acetilglutamin | |
Identifikacija | |
| |
3D model (Jmol) |
|
ChemSpider |
|
DrugBank |
|
ECHA InfoCard | 100.017.862 |
EC broj | 219-647-7 |
KEGG[1] |
|
MeSH | aceglutamide |
PubChem[2][3] C ID |
|
UNII |
|
SMILES
| |
Svojstva | |
C7H12N2O4 | |
Molarna masa | 188,18 g·mol−1 |
Agregatno stanje | Beli kristali |
Tačka topljenja | 197 °C (387 °F; 470 K) |
Srodna jedinjenja | |
Srodne alkanoinske kiseline |
|
Srodna jedinjenja |
|
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
Aceglutamid je psihostimulans i nutropik[4] koji se koristi za poboljšanje memorije i koncentracije.[5] Hemijski, on je acetilni derivat aminokiseline L-glutamina.
So aceglutamid aluminijum (KW-110, ili Glumal) je efektivna u tretmanu čireva.[6][7][8][9]
Aceglutamid se takođe može koristiti kao izvor glutamina koji je stabilian u tečnom stanju.[10][11][12]
Reference
- ^ Joanne Wixon; Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast. 17 (1): 48—55. doi:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Susan Budavari, ур. (2001). The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals (13th изд.). Merck Publishing. ISBN 0911910131.
- ^ Macdonald, F, ур. (1997). Dictionary of pharmacological agents. стр. A-00018. ISBN 978-0-412-46630-4.
- ^ Ito, M; Yokochi, E; Kobayashi, C; Suzuki, Y (1982). „Studies on defensive factors of experimental ulcers (2). Increasing action of aceglutamide aluminum on defensive factors in acetic acid ulcers of rats (author's transl)”. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 79 (4): 327—34. PMID 7095654.
- ^ Harada, Masatoshi; Yano, Shingo (1974). „Inhibitory effect of N-acetyl-L-glutamine aluminum complex (KW-110) and related compounds on gastric erosion and motility in stressed animals”. Oyo Yakuri. 8 (1): 1—6.
- ^ Varas Lorenzo, MJ; López Martínez, A; Gordillo Bernal, J; Mundet Surroca, J (1991). „Comparative study of 3 drugs (aceglutamide aluminum, zinc acexamate, and magaldrate) in the long-term maintenance treatment (1 year) of peptic ulcer”. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 80 (2): 91—4. PMID 1790087.
- ^ Tanaka, H; Shuto, K; Marumo, H (1982). „Effect of N-acetyl-L-glutamine aluminum complex (KW-110), an antiulcer agent, on the non-steroidal anti-inflammatory drug-induced exacerbation of gastric ulcer in rats”. Japanese journal of pharmacology. 32 (2): 307—13. PMID 7098147.
- ^ Lopez-Pedrosa Jose M; Manzano Manuel; Baxter Jeffrey H; Rueda Ricardo (2007). „N-acetyl-L-glutamine, a liquid-stable source of glutamine, partially prevents changes in body weight and on intestinal immunity induced by protein energy malnutrition in pigs”. Digestive diseases and sciences. 52 (3): 650—658. PMID 17253138. doi:10.1007/s10620-006-9500-y.
- ^ JP 10101576
- ^ US 2003099722
Литература
- Macdonald, F, ур. (1997). Dictionary of pharmacological agents. стр. A-00018. ISBN 978-0-412-46630-4.